Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Been diving into the medtech space lately and honestly, there's some compelling stuff happening here. The medical device sector isn't getting as much hype as biotech, but if you look at the numbers, the growth story is pretty solid.
So here's the thing about medical devices - they're basically everywhere in healthcare. We're talking surgical robots, glucose monitors, cardiac devices, imaging systems, all the tech that actually keeps people alive and healthy. And unlike pharma where you're betting on drug approvals, medtech companies are dealing with similar regulatory hurdles but often with more predictable outcomes once they hit the market.
The sector's expected to grow around 5% annually through 2030, which might not sound crazy but it's steady and reliable. What's really driving growth is AI integration - we're seeing smart wearables, AI-enabled diagnostics, robotic surgery systems becoming more sophisticated. Plus there's huge demand from aging populations dealing with chronic diseases like diabetes and cardiovascular issues.
If you want to get exposure, you've got two main paths. First, individual stocks. The big names are obvious - Abbott Laboratories, Intuitive Surgical with their da Vinci surgical system, Medtronic, Danaher, Thermo Fisher. These are the heavy hitters and honestly pretty stable holdings. But there are smaller plays too if you've got higher risk tolerance - companies like AngioDynamics focusing on vascular access, or Senseonics doing continuous glucose monitoring with implantable sensors.
Now here's where it gets interesting - if you want exposure without picking individual winners, ETFs are the cleaner route. The best medical device ETF options are pretty straightforward. You've got the iShares US Medical Devices ETF which is basically the largest in the space, tracking the Dow Jones Medical Equipment Index. Then there's the SPDR S&P Health Care Equipment ETF if you want S&P index exposure instead. Both give you diversification across the sector without having to research individual companies.
Honestly, the best medical device ETF for most people depends on your preference - do you want Dow Jones or S&P exposure? Either way, you're getting a basket of quality companies rather than betting on single product approvals. The ETF route also means you're not sweating individual clinical trial results or FDA decisions.
What I find interesting is how overlooked this sector seems compared to pure biotech. You get growth, you get stability, and you get real-world impact. Medical devices are actually being used right now helping patients, not waiting for regulatory approval. That's worth paying attention to.